Edward Cooper Stites (Edward Stites, Edward C Stites)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 16

Top Topics

Sickle Cell Disease

Peritoneal Dialysis

Tyrosine Kinase

Epidermal Growth Factor Receptor

Top Venues

American journal of hematology

NPJ systems biology and applications

Molecular & cellular oncology

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Satoko Ito, Ankur Pandya, Ronald George Hauser, Lakshmanan Krishnamurti, Edward Cooper Stites, Christopher A Tormey, Harlan M Krumholz, Jeanne Elise Hendrickson, George Goshua
Decreasing alloimmunization-specific mortality in sickle cell disease in the United States: Cost-effectiveness of a shared transfusion resource. American journal of hematology 99 (4) (2024)
Michael Trogdon, Kodye Abbott, Nadia Arang, Kathryn Lande, Navneet Kaur, Melinda Tong, Mathieu Bakhoum, Jorge Silvio Gutkind, Edward Cooper Stites
Systems modeling of oncogenic G-protein and GPCR signaling reveals unexpected differences in downstream pathway activation. NPJ systems biology and applications 10 (1) (2024)
Satoko Ito, Ankur Pandya, Ronald George Hauser, Lakshmanan Krishnamurti, Edward Cooper Stites, Christopher A Tormey, Harlan M Krumholz, Jeanne Elise Hendrickson, George Goshua
Decreasing alloimmunization-specific mortality in sickle cell disease in the United States: Cost-effectiveness of a shared transfusion resource. American journal of hematology 99 (4) (2024)
Satoko Ito, Ankur Pandya, Ronald George Hauser, Lakshmanan Krishnamurti, Edward Cooper Stites, Christopher A Tormey, Harlan M Krumholz, Jeanne Elise Hendrickson, George Goshua
Decreasing alloimmunization-specific mortality in sickle cell disease in the United States: Cost-effectiveness of a shared transfusion resource. American journal of hematology 99 (4) (2024)
Satoko Ito, Ankur Pandya, Ronald George Hauser, Lakshmanan Krishnamurti, Edward Cooper Stites, Christopher A Tormey, Harlan M Krumholz, Jeanne Elise Hendrickson, George Goshua
Decreasing alloimmunization-specific mortality in sickle cell disease in the United States: Cost-effectiveness of a shared transfusion resource. American journal of hematology 99 (4) (2024)
Satoko Ito, Ankur Pandya, Ronald George Hauser, Lakshmanan Krishnamurti, Edward Cooper Stites, Christopher A Tormey, Harlan M Krumholz, Jeanne Elise Hendrickson, George Goshua
Decreasing alloimmunization-specific mortality in sickle cell disease in the United States: Cost-effectiveness of a shared transfusion resource. American journal of hematology (2024)
Michael Trogdon, Kodye Abbott, Nadia Arang, Kathryn Lande, Navneet Kaur, Melinda Tong, Mathieu Bakhoum, Jorge Silvio Gutkind, Edward Cooper Stites
Systems modeling of oncogenic G-protein and GPCR signaling reveals unexpected differences in downstream pathway activation. NPJ systems biology and applications 10 (1) (2024)
Michael Trogdon, Kodye Abbott, Nadia Arang, Kathryn Lande, Navneet Kaur, Melinda Tong, Mathieu Bakhoum, Jorge Silvio Gutkind, Edward Cooper Stites
Systems modeling of oncogenic G-protein and GPCR signaling reveals unexpected differences in downstream pathway activation. NPJ systems biology and applications 10 (1) (2024)
Gaurav Mendiratta, Edward Cooper Stites
Theoretical analysis reveals a role for RAF conformational autoinhibition in paradoxical activation. eLife 12 (2023)
Gaurav Mendiratta, Michael K Jones, Edward Cooper Stites
How often is each gene mutated within the cancer patient population? Molecular & cellular oncology 9 (1) (2022)
Thomas McFall, Michael Trogdon, Anita C Guizar, John F Langenheim, Laura Sisk-Hackworth, Edward Cooper Stites
Co-targeting KRAS G12C and EGFR reduces both mutant and wild-type RAS-GTP. NPJ precision oncology 6 (1) (2022)
Gaurav Mendiratta, Eugene Ke, Meraj Aziz, David Liarakos, Melinda Tong, Edward Cooper Stites
Cancer gene mutation frequencies for the U.S. population. Nature communications 12 (1) (2021)
Thomas McFall, Edward Cooper Stites
A mechanism for the response of KRASG13D expressing colorectal cancers to EGFR inhibitors. Molecular & cellular oncology 7 (2) (2020)
Shumei Kato, Ki Hwan Kim, Hyo Jeong Lim, Amelie Boichard, Mina Nikanjam, Elizabeth Weihe, Dennis John Kuo, Ramez N Eskander, Aaron Goodman, Natalie Galanina, Paul T Fanta, Richard B Schwab, Rebecca Shatsky, Steven C Plaxe, Andrew Sharabi, Edward Cooper Stites, Jacob J Adashek, Ryosuke Okamura, Suzanna Lee, Scott M Lippman, Jason K Sicklick, Razelle Kurzrock
Real-world data from a molecular tumor board demonstrates improved outcomes with a precision N-of-One strategy. Nature communications 11 (1) (2020)
Thomas McFall, Noah K Schomburg, Kent L Rossman, Edward Cooper Stites
Discernment between candidate mechanisms for KRAS G13D colorectal cancer sensitivity to EGFR inhibitors. Cell communication and signaling : CCS 18 (1) (2020)
Thomas McFall, Jolene K Diedrich, Meron Mengistu, Stacy L Littlechild, Kendra V Paskvan, Laura Sisk-Hackworth, James J Moresco, Andrey S Shaw, Edward Cooper Stites
A systems mechanism for KRAS mutant allele-specific responses to targeted therapy. Science signaling 12 (600) (2019)